with severe inflammation and the production of a complex mixture of inflammatory mediators, extensive superficial mucosal ulceration develops. Histopathological features include crypt abscesses, the presence of a significant number of neutrophils within the lamina propria, and depletion of goblet cell mucin. Crohn's disease, on the other hand, can involve any site along the gastrointestinal tract and the inflammation is often patchy, segmental, and transmural; however, involvement of the terminal ileum is common with early lesions often appearing over Peyer's patches [3] . The underlying bases for these events most likely stem from an individual's genetic predisposition and development of a gut dysbiosis that compromises intestinal epithelial barrier function, mucosal immune responses, and tissue protective and wound healing responses.
The identification of genetic variations through genome-wide association studies gave great hope for predicting who is at increased risk for IBD. Although the clinical utility of this information has yet to be realized, important insights into the etiopathogenesis of IBD have been gained. They clearly provide strong support for a genetic basis for IBD, but they also point out that the development of these diseases involves other factors. For example, NOD2 mutations only account for 25% of Crohn's disease cases in Caucasians, and is not implicated in the pathogenesis of ulcerative colitis [4] . Furthermore, these genetic discoveries neither explain the variation in incidence between different populations, nor the rising incidence of disease in industrialized countries over the past 50 years [4] . These observations suggest that rapid shifts in environmental and perhaps even epigenetic factors are playing an increasing role in promoting the increased incidence of IBD. Together, this points to a 'multihit' hypothesis in which a genetically susceptible individual encounters a single or series of environmental triggers that tip the scale of a compensated immune response in favor of dysregulated inflammation.
While environmental triggers such as use of antibiotics, nonsteroidal anti-inflammatory drugs, smoking, and diet are widely cited in the pathogenesis of IBD, shifts in diet in Western countries and recently other industrialized nations have to be considered among these factors, as these changes are highly associated with a myriad of 'new age' complex immune diseases [5] . Specifically, modern conveniences, larger choices of low-cost caloriedense foods and sedentary lifestyle in industrialized countries have led to a culture of overindulgence and excess. Before the development of agriculture and animal husbandry, dietary choices were limited to minimally processed wild plant and animal foods. With domestication of plants and animals, dietary nutrient content subtly but progressively shifted toward more processed foods for which the human genome had little evolutionary experience [6] . Refined grains, sugars, vegetable oils, alcohol, salt, and fatty domesticated meats that were not present in the preagricultural diet now make up the primary constituents of the typical postagricultural Western diet that is consumed both out of balance and in caloric excess [6] . Thus, relatively rapid changes in Western lifestyle and diet have subjected the human condition to new stresses that challenge evolutionarily determined relationships between the host and environment. In the context of the gut, dietary antigens are the most common type of luminal antigen alongside bacterial antigens; therefore, it is reasonable to propose that they may play a significant role in IBD etiology. Possible mechanisms include the direct effect of dietary antigens, alteration of gene expression, changes in gastrointestinal permeability, and alteration of the composition and functional impact of the enteric flora.
In our studies, we investigated whether one major macronutrient of Western diets that has changed considerably over a short period of time, fat, has the ability to precipitate a compositional change in the gut microbiota depending on the type of fat consumed, and whether this change could differentially affect the onset and severity of experimental colitis. Appreciating the complex interplay of genetics, environment, immune response, and microbiota in the etiopathogenesis of IBD, we utilized the genetically predisposed mouse model for spontaneous colitis, the IL-10 -/-mouse, in both conventionalized and germ-free states, and created three high-fat diets that closely modeled the macronutrient composition of the standard American diet as reported by NHANES in 2011 [7] . The only variation between these diets was the type of fat used [safflower (SF), milk fat (MF), or lard]. With the exception of the low-fat (LF) purified mouse diet, the high-fat diets were isocaloric with fat composition held constant at 37% of total calories.
Genetically nonsusceptible C57BL/6j mice were exposed to the three study diets for 21 days, which resulted in significant differences in the structure of the enteric microbiota as assessed by both Sanger-based and 454-based DNA sequencing of 16S rRNA libraries from cecal contents and stool. The dramatic impact of these diets on the community structure of the microbiota was detectable within the first week of dietary intake. Each of the high-fat diets reduced the richness of the microbiota compared with the LF diet. Furthermore, the LF and lard-based diets promoted Firmicutes, but decreased most other phyla, whereas PUFA and MF diets promoted Bacteroidetes and decreased Firmicutes ( fig. 1 a) [8] . While MF and PUFA diets had similar effects on Bacteroidetes and Firmicutes, a significant bloom of a member of the Deltaproteobacteria, Bilophila wadsworthia , was consistently observed only with the highly saturated MF diet. Blooms of this rare microorganism most likely reflect changes in microbial assembly rules, thereby permitting its growth. In fact, B. wadsworthia is often detected as a highly abundant microbe in human pathological conditions such as appendicitis and other intestinal inflammatory disorders where it has been reported to be genotoxic as well as proinflammatory, owing to its immune-activating and sulfite-reducing properties. The sulfite-reducing properties, specifically, lead to abundant hydrogen sulfide production in conditions that favor blooms of this bacterium [9, 10] .
The unusual bloom of B. wadsworthia -from nearly undetectable on the LF diet to 5% abundance on MFprompted investigation into whether this diet-induced 'pathobiont' may precipitate disease in a genetically susceptible model. Indeed, the MF diet increased the onset and incidence of colitis in IL-10 -/-mice, driving it from a spontaneous rate of 25-30% (on LF) to 60% over a 6-month period [8] . In contrast, the incidence of colitis in IL-10 -/-mice fed the SF diet was no different than those fed the LF diet. The colitis seen in mice fed MF was also more severe and extensive, paralleling differences in histological colitis scores. Mucosal cytokine levels from the distal colon were significantly elevated compared to LF and was correlated to MF-induced blooms of B. wadsworthia as measured by qPCR. Collectively, these observations suggest that the bloom of sulfite-reducing Deltaproteobacteria, particularly B. wadsworthia , can promote colitis in hosts that are genetically susceptible or have compromised barrier function.
Studies in germ-free IL-10 -/-mice monoassociated with B. wadsworthia that were consuming either the LF, SF, or MF diet answered whether B. wadsworthia growth was truly MF-dependent. Five weeks after monoassociation, colonization of the colon could only be established in mice fed the MF diet, whereas on the LF or SF diet, fig. 1 b) . These colonized mice went on to develop colitis, characterized by large lymphoid aggregates (underdeveloped in uncolonized germfree mice), crypt hyperplasia, and immune cell infiltration [8] . This colitis was not as severe as when B. wads worthia blooms in the presence of other microbes, suggesting that the composite microbial community has the ability to keep certain pathobionts from growing uncontrollably. Furthermore, increased levels of Th1 cytokines, as well as low or undetectable levels of Th17 cytokines in the colonic mucosa of these mice, were consistent with the induction of a distinct Th1 immune response, which was further confirmed in the mesenteric lymph nodes (MLNs) of mice colonized on the MF diet [8] . None of these immune responses were observed in mice consuming the MF diet in the absence of B. wadsworthia , proving that the diet itself is not immunogenic. The response in IL-10 -/-MLNs was much greater than that in C57BL/6 MLNs, most likely due to the absence of IL-10-modulating signals. This suggested a genetic or microbially induced defect in mucosal barrier integrity could lead to increased uptake of luminal antigens and/or bacterial adjuvants that overwhelm the net suppressive tone of the mucosal immune system. Alternatively, a defect in epithelial repair could potentiate damage incurred by the MF diet that causes only transient damage in genetically normal or healthy hosts. The net effect of either pathway renders the gut mucosa to constant stimulation by innate and acquired mucosal immune responses by luminal adjuvants and antigens, respectively.
B. wadsworthia is a well-known sulfite reducer that uses sulfite as the terminal electron acceptor of the electron transport chain, resulting in the formation of H2S as a byproduct [11] . Thus, increased availability of organic sulfur promotes its growth under anaerobic conditions. One source for this is the sulfur moiety on the taurine-conjugated (TC) ( fig. 2 a) bile acids that are preferentially formed when exposed to MF diets, due to TC's ability to increase micellar formation and solubilization of milk fats [12] [13] [14] . Given that the literal meaning of Bilophilia is 'bile-loving', it has been well established that B. wadsworthia flourishes in the presence of bile in vitro, more specifically TC. Knowing this, we determined the ability of gallbladder aspirates obtained from mice on the three study diets to promote B. wadsworthia growth in vitro. First, mass spectrometry revealed that the bile composition in the gallbladder aspirates of mice consuming MF diet consisted primarily of TC, while LFand SF-fed mice First, mass spectrometry revealed taht the bile composition in the gallbladder aspirates of mice consuming MF diet consisted primarily of TC, while LF and SF-fed mice had significantly less TC in the total bile acid pool ( fig. 2 b) . and GC. These aspirates were then used to spike the liquid growth media of freshly inoculated cultures. Remarkably, B. wadsworthia growth was selectively and robustly stimulated by bile from MF-fed mice only. To determine whether the MF effect on B. wadsworthia was indeed mediated by TC in vivo, conventional IL-10 -/-mice were fed the LF diet only ( fig. 2 c) and gavaged with either TC or GC daily for 1 week. This resulted in a bloom of B. wadsworthia with TC, nearly identical to the bloom observed with consumption of the MF diet. In contrast, GC and PBS had little effect and B. wadsworthia remained undetectable. The bloom of B. wadsworthia observed in TC-gavaged mice was associated with increased incidence and severity of colitis, and Th1 cytokines were increased in both the mucosa and MLNs. Furthermore, monoassociation with B. wadsworthia can only be established in germ-free IL-10 -/-mice when accompanied by TC administration, and not by GC or PBS, as demonstrated by the reisolation of B. wadsworthia from the cecal contents of TC-fed mice. These mice developed colitis, and again exhibited elevated Th1 mucosal and MLN intracellular cytokines. Thus, the effects of MF on the microbiota, mucosal immunity, and colitis can be reproduced by TC.
This study supports the notion that the composition of dietary fats results in differential effects on the enteric microbiota leading to shifts in the host inflammatory response. The bloom of sulfite-reducing bacteria such as B. wadsworthia occurs through a unique mechanism involving MF-promoted taurine conjugation of hepatic bile acids, which, through repeated cycles of the enterohepatic circulation, increases sulfhydryl bioavailability that promotes the growth of colonic microbiota capable of sulfite reduction ( fig. 3 ). These types of bacteria are of great clinical interest as they are often recovered from biopsies and stool of IBD patients [15] [16] [17] [18] , and in our studies appear to have a strong correlation to severity of colitis. This, in turn, begs the question of how to reverse such dysbiosis. From a dietary standpoint, great promise exists for nutritional therapy in reshaping the microbiome. Many individuals with IBD search for complementary and alternative treatments to help ease their symptoms. While as many as half of all Crohn's patients may turn to these types of treatments, few have been rigorously studied for efficacy, safety, and mechanism of action. For years, fish oil supplements have been attempted for treatment of IBD with hopeful yet varied results [19, 20] . The mechanism of their action in IBD is unknown, but has been attributed to their anti-inflammatory effects, primarily mediated by docosahexaenoic and eicosapentaenoic ω-3 fatty acids [21] . However, equally plausible is the possibility that ω-3 fatty acids change the enteric microbiome in a way that may be less immunogenic and disease-promoting in individuals genetically prone to IBD.
In a follow-up set of unpublished studies, we asked whether there might be a beneficial way to manipulate fats to suppress growth of pathobionts through ω-3 supplementation. Findings from these studies revealed that a 5% supplementation of our established proinflammatory MF diet with ω-3 fish oil completely inhibited blooms of B. wadsworthia , resulting in lower incidence and severity of colitis similar to mice consuming LF. Furthermore, cytokines at both the mucosal and MLN levels were reduced in the group supplemented with ω-3 compared to MF alone, and not statistically different from LF control. The above effects appear to be mediated through a shift in bile acid composition by ω-3 supplementation.
The dynamic interplay of diets, host physiology, and the microbiome triangulate in such a way that it is never unidirectional. Our microbiome can be modulated, groomed, and reshaped by the foods we eat and our underlying host chemistry. In these studies, we show one possible pathway in which the fats we choose to consume on a regular basis can indirectly influence the gut microbiota through altered bile acid composition, and depending on your fat of choice, could lead to disease or prevent it. Further studies in humans are necessary to understand References the long-term consequences of diets on the microbiome and disease susceptibility, but the existing evidence to date makes clear that our intestinal microbes are exquisitely sensitive to our dietary choices.
